TP53 and hepatocellular carcinoma: Their results showed that the TP53 c.747G > T (p.R249S) mutation was found in ~20% of the HCC plasma samples and in only ~3–4% of the pancreatic and stomach cancer samples, and it was not detected in a large cohort of 812 healthy controls.